5. Progressive supranuclear palsy Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 89 / Drugs : 107 - (DrugBank : 40) / Drug target genes : 65 - Drug target pathways : 108
Progressive supranuclear palsy and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
ID | Diseases (Sorted by score) | Score |
---|---|---|
5 | Progressive supranuclear palsy | - |
6 | Parkinson disease | 60.082 |
13 | Multiple sclerosis/Neuromyelitis optica | 53.116 |
2 | Amyotrophic lateral sclerosis | 52.309 |
17 | Multiple system atrophy | 41.368 |
3 | Spinal muscular atrophy | 37.572 |
206 | Fragile X syndrome | 36.011 |
8 | Huntington disease | 30.643 |
156 | Rett syndrome | 28.720 |
22 | Moyamoya disease | 26.436 |
70 | Spinal stenosis | 26.138 |
18 | Spinocerebellar degeneration | 24.615 |
46 | Malignant rheumatoid arthritis | 23.064 |
97 | Ulcerative colitis | 22.800 |
96 | Crohn disease | 21.066 |
21 | Mitochondrial disease | 20.283 |
140 | Dorabe syndrome | 20.094 |
193 | Prader-Willi syndrome | 19.572 |
205 | Fragile X syndrome related disease | 18.726 |
34 | Neurofibromatosis | 18.292 |
296 | Biliary atresia | 18.162 |
144 | Lennox-Gastaut syndrome | 17.465 |
158 | Tuberous sclerosis | 16.594 |
152 | PCDH19 related syndrome | 16.000 |
201 | Angelman syndrome | 15.634 |
98 | Eosinophilic gastrointestinal disease | 14.066 |
203 | 22q11.2 deletion syndrome | 14.000 |
231 | Alpha-1-antitrypsin deficiency | 12.853 |
145 | West syndrome | 12.350 |
127 | Frontotemporal lobar degeneration | 11.941 |
215 | Tetralogy of Fallot | 11.559 |
272 | Fibrodysplasia ossificans progressiva | 11.361 |
155 | Acquired aphasia with convulsive disorder | 10.593 |
298 | Hereditary pancreatitis | 9.405 |
169 | Menkes disease | 9.000 |
170 | Occipital horn syndrome | 9.000 |
36 | Epidermolysis bullosa | 8.802 |
113 | Muscular dystrophy | 8.063 |
75 | Cushing disease | 7.888 |
85 | Idiopathic interstitial pneumonia | 7.351 |
102 | Rubinstein-Taybi syndrome | 7.000 |
86 | Pulmonary arterial hypertension | 6.580 |
84 | Sarcoidosis | 6.292 |
118 | Myelomeningocele | 6.219 |
4 | Primary lateral sclerosis | 5.992 |
26 | HTLV-1-associated myelopathy | 5.305 |
256 | Muscle glycogenosis | 5.104 |
254 | Porphyria | 4.919 |
11 | Myasthenia gravis | 4.825 |
233 | Wolfram syndrome | 4.729 |
226 | Interstitial cystitis with Hunners ulcer | 4.713 |
89 | Lymphangioleiomyomatosis | 4.672 |
90 | Retinitis pigmentosa | 4.612 |
7 | Corticobasal degeneration | 4.185 |
78 | Hypopituitarism | 4.146 |
65 | Primary immunodeficiency | 4.102 |
299 | Cystic fibrosis | 3.438 |
58 | Hypertrophic cardiomyopathy | 3.301 |
323 | Aromatic L-amino acid decarboxylase deficiency | 3.000 |
57 | Idiopathic dilated cardiomyopathy | 2.949 |
280 | Huge arteriovenous malformation with cervicofacial or limb lesion | 2.888 |
222 | Primary nephrotic syndrome | 2.390 |
288 | Autoimmune acquired coagulation factor deficiency | 2.369 |
331 | Idiopathic multicentric castleman disease | 2.164 |
210 | Single Ventricle | 2.120 |
337 | Homocystinuria | 2.000 |
49 | Systemic lupus erythematosus | 1.858 |
278 | Huge lymphatic malformation with cervicofacial lesion | 1.855 |
212 | Tricuspid atresia | 1.212 |
107 | Juvenile idiopathic arthritis | 1.182 |
53 | Sjogren syndrome | 1.148 |
51 | Scleroderma | 1.141 |
149 | Hemiconvulsion hemiplegia epilepsy syndrome | 1.129 |
28 | Systemic amyloidosis | 1.049 |
251 | Urea cycle disorder | 1.031 |
19 | Lysosomal storage disease | 1.027 |
111 | Congenital myopathy | 1.000 |